February 4, 2010 Tacere Therapeutics achieves significant milestone in collaboration and license agreement with Pfizer
March 12, 2008 Oncolys BioPharma and Tacere Therapeutics sign strategic alliance and license agreement to develop and commercialize RNAi Hepatitis C drug
January 7, 2008 Tacere Therapeutics enters collaboration and license agreement with Pfizer to develop and commercialize RNAi Hepatitis C drug
October, 2007 | Pharmaceutical Approvals Monthly The State of RNA Interference
June 21, 2007 Oncolys BioPharma and Tacere Therapeutics form strategic alliance to develop RNAi Hepatitis C drug
October 12, 2006 Tacere Therapeutics secures financing and resumes development of RNAi Hepatitis C drug.
October 12, 2006 | Dow Jones VentureWire Hepatitis C Company Tacere Launches with Seed Round.
October 3, 2006 | The Wall Street Journal Online Nobel Discovery Already Sparked Hunt for Drugs.
